Avantor, Inc. (NYSE:AVTR) Stock Position Raised by Connor Clark & Lunn Investment Management Ltd.

Connor Clark & Lunn Investment Management Ltd. lifted its position in Avantor, Inc. (NYSE:AVTR) by 1,802.6% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 532,365 shares of the company’s stock after buying an additional 504,384 shares during the quarter. Connor Clark & Lunn Investment Management Ltd. owned about 0.08% of Avantor worth $13,772,000 as of its most recent filing with the SEC.

A number of other hedge funds have also recently added to or reduced their stakes in the company. SG Americas Securities LLC acquired a new position in shares of Avantor during the 1st quarter valued at about $159,000. Acadian Asset Management LLC raised its position in shares of Avantor by 45.8% in the first quarter. Acadian Asset Management LLC now owns 22,678 shares of the company’s stock valued at $579,000 after purchasing an additional 7,120 shares during the period. UniSuper Management Pty Ltd lifted its stake in shares of Avantor by 97.9% in the first quarter. UniSuper Management Pty Ltd now owns 9,500 shares of the company’s stock worth $243,000 after buying an additional 4,700 shares during the last quarter. CANADA LIFE ASSURANCE Co boosted its holdings in shares of Avantor by 0.6% during the 1st quarter. CANADA LIFE ASSURANCE Co now owns 553,982 shares of the company’s stock worth $14,168,000 after buying an additional 3,038 shares during the period. Finally, Quadrature Capital Ltd grew its stake in Avantor by 45.3% in the 1st quarter. Quadrature Capital Ltd now owns 18,265 shares of the company’s stock valued at $467,000 after buying an additional 5,695 shares during the last quarter. Institutional investors and hedge funds own 95.08% of the company’s stock.

Insider Transactions at Avantor

In related news, CAO Steven W. Eck sold 3,525 shares of the company’s stock in a transaction on Thursday, September 5th. The shares were sold at an average price of $25.06, for a total value of $88,336.50. Following the completion of the sale, the chief accounting officer now owns 29,544 shares in the company, valued at $740,372.64. This represents a 10.66 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 1.50% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts have issued reports on the stock. Stifel Nicolaus upped their price target on shares of Avantor from $27.00 to $28.00 and gave the company a “buy” rating in a report on Monday, July 29th. Barclays decreased their target price on Avantor from $28.00 to $25.00 and set an “overweight” rating for the company in a research note on Friday, October 25th. UBS Group cut their price target on Avantor from $30.00 to $29.00 and set a “buy” rating for the company in a report on Tuesday, October 8th. Wells Fargo & Company lowered their price objective on shares of Avantor from $30.00 to $28.00 and set an “overweight” rating on the stock in a research note on Monday, October 28th. Finally, Morgan Stanley upped their target price on shares of Avantor from $28.00 to $29.00 and gave the company an “overweight” rating in a research note on Monday, July 29th. Three investment analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $27.57.

Avantor Stock Up 1.1 %

Shares of Avantor stock opened at $20.36 on Friday. The business has a fifty day simple moving average of $24.01 and a 200 day simple moving average of $23.89. The stock has a market cap of $13.86 billion, a PE ratio of 44.26, a price-to-earnings-growth ratio of 2.39 and a beta of 1.35. The company has a quick ratio of 1.06, a current ratio of 1.54 and a debt-to-equity ratio of 0.84. Avantor, Inc. has a 12 month low of $19.59 and a 12 month high of $28.00.

Avantor Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.